Drugs / bone marrow concentrate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02890537 Comparator | Oct 2003 → May 2011 | avascular necrosis | Erasme University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow concentrate | “bone marrow concentrate (BMC) when implanted at the osteonecrotic lesion of the femoral head” NCT02890537 ↗ |
| Known as | BMC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02890537 ↗ |
| Route | Other | “implantation of BMC into the necrotic lesion” NCT02890537 ↗ |